Press Releases

Biomarkers Market Revenue to Reach Nearly US$ 207.46 Billion By 2030

The biomarkers market size was USD 63.06 billion in 2021 and is expected to reach USD 207.46 billion by 2030. It is anticipated to grow with a healthy CAGR of 14.1% from 2021 to 2030.

In 2022, the biomarkers market study provides crucial information on market share, market size, growth rate analysis Y-O-Y, production, consumption, and sales analysis for the forecast period 2021 to 2030. The report contains 150+ pages with detailed analysis.

A biomarker is a biological molecule or gene that is used to evaluate pharmaceutical reactions, biological processes, and pathogenic procedures in an effective and accurate manner. Biomarkers can be found in blood, other than bodily fluids, and tissue and are also known as molecular markers or signature molecules.

Diagnostic markets are becoming increasingly demanding. Traditionally, diagnostic instruments were focused on delivering accurate and consistent results; however, the biomarkers market demand includes early diagnosis with consistent and accurate outcomes. Accurately reporting results in the early stages of diseases, particularly cancer, presents considerable obstacles.

The demand for precise diagnostic techniques is growing as the number of life-threatening and chronic disorders rises. Globally, the number of biomarker suppliers, service providers, and producers is increasing, resulting in tremendous biomarkers market potential opportunities.

Report Scope of the Biomarkers Market

Report Highlights Details
Market Size USD 207.46 Billion by 2030
Growth Rate CAGR of 14.1% from 2021 to 2030
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Type, Application, Disease

COVID-19 Impact:

The industrial report mentions the influence of the ongoing COVID-19 pandemic. The outbreak has caused disturbances in several industries and has hammered the logistics, resulting in delayed deliveries and cancellation of product demand. The biomarkers report proficiently explains the resulting factors and concerns of manufacturers. Researchers have also well-explained how the producers and providers will tackle the ongoing epidemic and the key strategies to be adopted post-pandemic for turning their businesses back to normal.

Regional Snapshot

North America is the largest segment for biomarkers market in terms of region.This is attributed to an increase in diseases rates, increased consumer awareness, and technological advances, and improvements in healthcare infrastructure.

Europe region is the fastest growing region in the biomarkers market. This is due to the existence of well-known research institutes and major market players in the region. The increased collaborations between European universities and biomarkers solutions suppliers can be related to the market’s expansion. The Europe region’s healthcare services are likely to improve as biomarker testing becomes more widely available, boosting the growth of the biomarkers market.

Key Players:

The biomarkers market is consolidated with a major number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues. In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research.

Some of the prominent players in the biomarkers market include:

  • Bio-Rad Laboratories, Inc.
  • Qiagen
  • Epigenomics AG
  • Abbott
  • Hoffmann-La Roche Ltd.
  • Agilent Technologies, Inc.
  • Johnson & Johnson Services, Inc.
  • Abbott
  • Siemens
  • Thermo Fisher Scientific, Inc.

Market Segmentation

By Type

  • Validation
  • Efficacy
  • Safety

By Disease

  • Neurological Diseases
  • Cancer
  • Immunological Diseases
  • Cardiovascular Diseases
  • Others

By Application

  • Personalized Medicines
  • Drug Discovery & Development
  • Diagnostics
  • Others

Regional Segmentation

  • North America (U.S. and Canada)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Find More Press Releases at https://www.globenewswire.com/en/search/organization/Precedence%2520Research

Frequently Asked Questions?

  • What is the total market value?
  • What will be the growth in 2030?
  • What are the key trends in the market?
  • What are the major players in biomarkers markets?
  • What are the key growth strategies of industry players?
  • Which region would offer a higher growth?
  • What are the countries included in the rest of the word segments?
  • How can I get report sample?

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot

Chapter 4. Biomarkers Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Biomarkers Market

5.1. Covid-19: Biomarkers Industry Impact
5.2. Biomarkers Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Biomarkers Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Biomarkers Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Biomarkers Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Rising incidences of cancer
6.1.1.2. Increasing focus on establishment of biomarker-based diagnostic methods
6.1.2. Market Restraints
6.1.2.1. Stringent regulations
6.1.3. Market Opportunities
6.1.3.1. Rapidly expanding applications of biomarkers in diagnostics
6.1.3.2. Technological advancements

Chapter 7. Global Biomarkers Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Biomarkers Market Revenue by Market Players (2019 -2020)
7.1.1.2. Biomarkers Market Revenue Market Share by Market Players (2019 -2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Type Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Biomarkers Market, By Type

8.1. Biomarkers Market, by Type, 2019-2030
8.1.1. Validation
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Efficacy
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Safety
8.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Biomarkers Market, By Disease

9.1. Biomarkers Market, by Disease, 2019-2030
9.1.1. Neurological Diseases
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Cancer
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Immunological Diseases
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Cardiovascular Diseases
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Biomarkers Market, By Application

10.1. Biomarkers Market, by Application, 2019-2030
10.1.1. Personalized Medicines
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Drug Discovery & Development
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Diagnostics
10.1.3.1. Market Revenue and Forecast (2019-2030)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 11. Global Biomarkers Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue Forecast by Type(2019-2030)
11.1.2. Market Revenue Forecast by Disease (2019-2030)
11.1.3. Market Revenue Forecast by Application (2019-2030)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2019-2030)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2019-2030)
11.2. Europe
11.2.1. Market Revenue Forecast by Type (2019-2030)
11.2.2. Market Revenue Forecast by Disease (2019-2030)
11.2.3. Market Revenue Forecast by Application (2019-2030)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2019-2030)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2019-2030)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2019-2030)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2019-2030)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Type (2019-2030)
11.3.2. Market Revenue Forecast by Disease (2019-2030)
11.3.3. Market Revenue Forecast by Application (2019-2030)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2019-2030)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2019-2030)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2019-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2019-2030)
11.4. LATAM
11.4.1. Market Revenue Forecast by Type (2019-2030)
11.4.2. Market Revenue Forecast by Disease (2019-2030)
11.4.3. Market Revenue Forecast by Application (2019-2030)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2019-2030)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2019-2030)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Type (2019-2030)
11.5.2. Market Revenue Forecast by Disease (2019-2030)
11.5.3. Market Revenue Forecast by Application (2019-2030)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2019-2030)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2019-2030)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2019-2030)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2019-2030)

Chapter 12. Company Profiles

12.1. Bio-Rad Laboratories, Inc.
12.1.1. Company Overview, Business Information, Regional Presence
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Disease
12.1.3. Revenue, Price, and Gross Margin (2015-2020)
12.1.4. Recent Developments and Strategies
12.2. Qiagen
12.2.1. Company Overview, Business Information, Regional Presence
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Disease
12.2.3. Revenue, Price, and Gross Margin (2015-2020)
12.2.4. Recent Developments and Strategies
12.3. Epigenomics AG
12.3.1. Company Overview, Business Information, Regional Presence
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Disease
12.3.3. Revenue, Price, and Gross Margin (2015-2020)
12.3.4. Recent Developments and Strategies
12.4. Abbott
12.4.1. Company Overview, Business Information, Regional Presence
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Disease
12.4.3. Revenue, Price, and Gross Margin (2015-2020)
12.4.4. Recent Developments and Strategies
12.5. F. Hoffmann-La Roche Ltd.
12.5.1. Company Overview, Business Information, Regional Presence
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Disease
12.5.3. Revenue, Price, and Gross Margin (2015-2020)
12.5.4. Recent Developments and Strategies
12.6. Agilent Technologies, Inc.
12.6.1. Company Overview, Business Information, Regional Presence
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Disease
12.6.3. Revenue, Price, and Gross Margin (2015-2020)
12.6.4. Recent Developments and Strategies
12.7. Johnson & Johnson Services, Inc.
12.7.1. Company Overview, Business Information, Regional Presence
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Disease
12.7.3. Revenue, Price, and Gross Margin (2015-2020)
12.7.4. Recent Developments and Strategies
12.8. Abbott
12.8.1. Company Overview, Business Information, Regional Presence
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Disease
12.8.3. Revenue, Price, and Gross Margin (2015-2020)
12.8.4. Recent Developments and Strategies
12.9. Siemens
12.9.1. Company Overview, Business Information, Regional Presence
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Disease
12.9.3. Revenue, Price, and Gross Margin (2015-2020)
12.9.4. Recent Developments and Strategies
12.10. Thermo Fisher Scientific, Inc.
12.10.1. Company Overview, Business Information, Regional Presence
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Disease
12.10.3. Revenue, Price, and Gross Margin (2015-2020)
12.10.4. Recent Developments and Strategies

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:         

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Show More

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Back to top button